Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis

Neurology

Volumn 79, Issue 13, 2012, Pages 1363-1368

  Sundqvist, Emilie ^a   Sundström, Peter ^b   Lindén, Magdalena ^a   Hedström, Anna Karin ^a   Aloisi, Francesca ^c   Hillert, Jan ^a   Kockum, Ingrid ^a   Alfredsson, Lars ^a   Olsson, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; HLA DR ANTIGEN; HLA DRA02 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB115 ANTIGEN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENOTYPE; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SWEDEN; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84866887824     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826c1ab7     Document Type: Article

References (13)

1. Brynedal B, Duvefelt K, Jonasdottir G, et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2007;2:e664.
2. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010;6:156-166.
3. Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti-EBNA antibodies, and HLADRB1 1501 on multiple sclerosis risk. Neurology 2010; 74:1365-1371.
4. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-579.
5. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009;73:696-701.
6. Sundqvist E, Sundstrom P, Linden M, et al. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun Epub 2011.
7. Kallberg H, Ahlbom A, Alfredsson L. Calculating measures of biological interaction using R. Eur J Epidemiol 2006;21:571-573.
8. Hedstrom AK, Sundqvist E, Baarnhielm M, et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 2011;134: 653-664.
9. Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008;41:298-328.
10. Rand KH, Houck H, Denslow ND, Heilman KM. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65:48-55.
11. Shan M, Cheng HF, Song LZ, et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 2009;1:4-10.
12. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-1492.
13. Doyle HA, Mamula MJ. Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 2002;14:244-249.